Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002000 · ClinicalTrials.gov registry record · NA
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
A NA study, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
NCT00002000: Completed NA study, sponsored by Glaxo Wellcome.
NCT00002000 is a NA study that has completed, run by Glaxo Wellcome. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002000, a NA study, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and efficacy of oral valacyclovir hydrochloride (256U87) vs. acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients (CD4 greater than or equal to 100).
Interventions
- DRUG Acyclovir
- DRUG Valacyclovir hydrochloride
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002000 record still lists
NCT00002000 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Acyclovir is the first listed.
NCT00002000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002000 about?
NCT00002000 is a clinical study titled "A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients". To evaluate the safety and efficacy of oral valacyclovir hydrochloride (256U87) vs. acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients (CD4 greater than or equal to 100).
What is the current status of trial NCT00002000?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002000?
The interventions under investigation include: Acyclovir (DRUG), Valacyclovir hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002000?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.